Article info
PDFShort report
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
- Correspondence to Mr Peter Armstrong, Pharmacy Department, Belfast Health and Social Care Trust, Belfast, UK; peter.armstrong{at}belfasttrust.hscni.net
Citation
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
Publication history
- Received March 3, 2017
- Revision received August 9, 2017
- Accepted August 16, 2017
- First published September 1, 2017.
Online issue publication
February 15, 2018
Article Versions
- Previous version (15 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/